DHFS-MCO PREFERRED DRUG LISTS House SponsorsRep. Sara Feigenholtz-Gregory Harris, Kelly M. Cassidy, Theresa Mah, Michael Halpin, Elizabeth Hernandez, Delia C. Ramirez and Karina Villa Senate Sponsors(Sen. Julie A. Morrison and Laura Fine) 7/12/2019HousePublic Act . . . . . . . . . 101-0062 305 ILCS 5/5-30.11 new Amends the Medical Assistance Article of the Illinois Public Aid Code. Requires the Department of Healthcare and Family Services to develop, no later than January 1, 2020, a standardized format for all Medicaid managed care organization preferred drug lists in collaboration with Medicaid managed care organizations and other stakeholders, including, but not limited to, organizations that serve individuals impacted by HIV/AIDS or epilepsy, and community-based organizations, providers, and entities with expertise in drug formulary development. Requires the Department to allow Medicaid managed care organizations 6 months from the completion date of the standardized format to comply with the new Preferred Drug List format. Requires each Medicaid managed care organization to post its preferred drug list on its website without restricting access and to update the preferred drug list posted on its website no less than 30 days prior to the date upon which any update or change takes effect. Requires the Department to establish, no later than January 1, 2020, the Illinois Drug and Therapeutics Advisory Board to have the authority and responsibility to provide recommendations to the Department regarding which drug products to list on the Department's preferred drug list. Contains provisions concerning Board meetings and correspondence; the Board's composition; voting and non-voting members; and other matters. Requires the Department to adopt rules, to be in place no later than January 1, 2020, for the purpose of establishing and maintaining the Board. Effective immediately.House Floor Amendment No. 2 Expands the membership on the Illinois Drug and Therapeutics Advisory Board by including the following members: (1) at least one clinician who specializes in the prevention and treatment of HIV, recommended by an HIV healthcare advocacy organization; and (2) at least one clinician recommended by a healthcare advocacy organization that serves individuals who are affected by chronic diseases that require significant pharmaceutical treatments. Provides that one non-voting clinician recommended by an association of Medicaid managed care health plans shall serve a term of 3 years on the Board without compensation. Includes organizations that serve individuals with rare diseases to the list of organizations that the Department of Healthcare and Family Services must collaborate with when developing a standardized format for all Medicaid managed care organization preferred drug lists. Provides that a licensed physician recommended by the Rare Disease Commission who is a rare disease specialist and possesses scientific knowledge and medical training with respect to rare diseases and is familiar with drug and biological products and treatment shall be notified in advance to attend an Illinois Drug and Therapeutics Advisory Board meeting when a drug or biological product is scheduled to be reviewed in order to advise and make recommendations on drugs or biological products. Makes technical changes. 2/7/2019HouseFiled with the Clerk by Rep. Sara Feigenholtz 2/7/2019HouseFirst Reading 2/7/2019HouseReferred to Rules Committee 2/19/2019HouseAssigned to Appropriations-Human Services Committee 2/19/2019HouseAdded Chief Co-Sponsor Rep. Gregory Harris 3/6/2019HouseAdded Co-Sponsor Rep. Kelly M. Cassidy 3/19/2019HouseAdded Co-Sponsor Rep. Theresa Mah 3/19/2019HouseAdded Co-Sponsor Rep. Michael Halpin 3/21/2019HouseDo Pass / Short Debate Appropriations-Human Services Committee; 019-000-000 3/21/2019HousePlaced on Calendar 2nd Reading - Short Debate 3/21/2019HouseAdded Co-Sponsor Rep. Elizabeth Hernandez 3/28/2019HouseAdded Co-Sponsor Rep. Delia C. Ramirez 3/29/2019HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Sara Feigenholtz 3/29/2019HouseHouse Floor Amendment No. 1 Referred to Rules Committee 4/2/2019HouseHouse Floor Amendment No. 1 Rules Refers to Appropriations-Human Services Committee 4/4/2019HouseHouse Floor Amendment No. 2 Filed with Clerk by Rep. Sara Feigenholtz 4/4/2019HouseHouse Floor Amendment No. 2 Referred to Rules Committee 4/9/2019HouseHouse Floor Amendment No. 2 Rules Refers to Appropriations-Human Services Committee 4/9/2019HouseHouse Floor Amendment No. 2 Recommends Be Adopted Appropriations-Human Services Committee; 011-000-000 4/10/2019HouseSecond Reading - Short Debate 4/10/2019HouseHouse Floor Amendment No. 2 Adopted 4/10/2019HousePlaced on Calendar Order of 3rd Reading - Short Debate 4/11/2019HouseThird Reading - Short Debate - Passed 112-000-001 4/11/2019HouseHouse Floor Amendment No. 1 Tabled 4/11/2019HouseAdded Co-Sponsor Rep. Karina Villa 4/11/2019SenateArrive in Senate 4/11/2019SenatePlaced on Calendar Order of First Reading 4/11/2019SenateChief Senate Sponsor Sen. Julie A. Morrison 4/11/2019SenateFirst Reading 4/11/2019SenateReferred to Assignments 4/24/2019SenateAssigned to Human Services 5/2/2019SenateDo Pass Human Services; 009-000-000 5/2/2019SenatePlaced on Calendar Order of 2nd Reading May 7, 2019 5/10/2019SenateAdded as Alternate Co-Sponsor Sen. Laura Fine 5/14/2019SenateSecond Reading 5/14/2019SenatePlaced on Calendar Order of 3rd Reading May 15, 2019 5/16/2019SenateThird Reading - Passed; 057-000-000 5/16/2019HousePassed Both Houses 6/14/2019HouseSent to the Governor 7/12/2019HouseGovernor Approved 7/12/2019HouseEffective Date July 12, 2019 7/12/2019HousePublic Act . . . . . . . . . 101-0062